Back to SLNCF
TCG Crossover Management, LLC → SLNCF
TCG Crossover Management, LLC SLNCF Position History
Silence Therapeutics plc • Healthcare
Quarters held
4
Latest value
$19.9M
Q3 2026
Peak value
$33.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $18.4M |
| Q1 2026 | $16M |
| Q2 2026 | $33.3M |
| Q3 2026 | $19.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19.9M | 1.82M | — | — |
| Q2 2026 | $33.3M | 3.03M | — | — |
| Q1 2026 | $16M | 3.03M | — | — |
| Q4 2025 | $18.4M | 3.03M | — | — |
Other funds holding SLNCF
$44.5M
$36.4M
$31.6M
$29.4M
$26.9M
$26.6M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC